Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US
LinkedIn View on LinkedIn
Mark Yondola, Ph.D., Founder & Chief Science Officer of Calder Biosciences Ph.D.: Stony Brook University, Molecular and Cellular Pharmacology Dr. Yondola did his postdoctoral fellowship at Mount Sinai with Dr. Peter Palese. He has since established Calder’s 3D-VaxLock platform technology and developed the cell line, processes & analytics
for the clinical manufacture of the DT-PreF RSV vaccine. Mark is the principal investigator of the company's current applications & awards, and has served on multiple NIH/DOD review panels.
